expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology TodayRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe DiplomatThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)Večer
العين الإخبارية 
Toi StaffAgenciesEmanuel FabianJacob MagidReutersJeremy Sharon
Gideon LevySam SokolLazar BermanCanaan LidorRon KampeasThe Japan News EditorialAmy SpiroDavid HorovitzLuke TressCathryn J. PrinceOthman Moqbel
Belen Fernandez
Rami G KhouriAmérica EconomíaJessica SteinbergJennifer HolleisRenee Ghert-ZandCharlie Summers
Mort LaitnerMatt LebovicElana KirshThe Asahi ShimbunCarolina LandsmannAeon Video
Rachel MarsdenEhud Olmert
Bradley BlankenshipSharon WrobelSlavoj ŽižekJacob GurvisE-International RelationsMikhael ManekinEfrat RaytenGavriel Fiske
Tarik Cyril AmarFred SchwallerGianluca Pacchiani
Michael KwetAya GruberDylan LohEugene BrusilovskiyAnonymousJapan TodayMurali Krishnan
|
|
Bruce GilQuartz |
Pharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles with diminishing demand for its COVID-19 vaccine....
BuzzFeed stock soared during Wednesday trading following the news that former GOP presidential nominee Vivek Ramaswamy has bought an activist stake in...
Staff at the U.S. Food and Drug Administration (FDA) said on Wednesday that Novo Nordisk’s experimental weekly insulin, Awiqli, carried a higher...
Biotechnology giant Biogen said on Wednesday that it is acquiring immune drug developer Human Immunology Biosciences (HI-Bio) to boost its late-stage...
People suffering from a severe form of asthma could soon see their symptoms improve with a new medication that only needs to be administered twice a...
The millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in offering customers a compounded version of...
Cambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19...
Those considering whether to try medications like Ozempic for weight loss may soon be able to tell how effective the treatment will be for them....
The millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering customers a compounded version of semaglutide, the active...
The U.S. Food and Drug Administration (FDA) has given Elon Musk’s startup Neuralink the official go-ahead to implant its experimental brain chip on...
Danish pharma giant Novo Nordisk launched its game-changing diabetes medication Ozempic in 2017. The weekly injection helps people with type-2...
It may take a weight loss pill for Eli Lilly to finally meet demand for its popular anti-obesity medications, according to the pharma giant’s top...
People who depend on daily insulin shots may soon have welcome news: a new experimental drug could cut their treatments down from daily doses to...
Swiss pharma giant Roche posted positive results on Thursday of its phase-1 clinical trail for its experimental weight loss drug CT-388.Read more...
A bipartisan bill that would prohibit American agencies from working with several Chinese biotech companies, thanks to national security concerns,...
The number of active monthly users of Netflix’s ad-supported plan skyrocketed 700% to 40 million this year, compared with 5 million in 2023, the...
Elon Musk’s brain chip startup has known about a design flaw in its brain implant’s electrode-containing threads for years, according to a new...
U.S. Secretary of Transportation Pete Buttigieg is calling out airlines for suing to block a new rule from the Biden administration meant to...
Danish pharma giant Novo Nordisk, the maker of the popular diabetes and weight loss drugs Ozempic and Wegovy, has a prominent admirer in its home...
It may take a weight loss pill for Eli Lilly to finally meet demand for its popular anti-obesity medications, according to Eli Lilly’s top leader...
Two new analyses of the longest clinical trial of semaglutide — the active ingredient in Wegovy — have shed some light on the long-term effects of...
British mining giant Anglo American said on Tuesday that is planning to spin off its iconic De Beers diamond brand to “improve strategic...
Kenvue, the maker of popular consumer health brands like Tylenol and Listerine, announced Monday that Johnson & Johnson is selling its remaining...
Merck announced Monday that it is pulling the plug on its phase 3 trial of an experimental combination treatment for skin cancer after side effects...
Microsoft, Amazon, Pfizer, and other corporations announced Monday that they are investing a record 15 million euros ($16.2 billion) in France.Read...
The U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time, disputing hundreds of “junk” patents listed in the...
Cambridge, U.K.-based pharma giant AstraZeneca said on Wednesday that it is no longer producing or supplying its COVID-19 vaccine, known as...
New York, Tokyo, and Paris are among the cities with the most wealthy residents, according to a new report by Henley & Partners, a firm that...
Amazon is making it easier than ever for users of its video streaming service to buy directly from commercials. The e-commerce giant announced Tuesday...
Every pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar drug that dominates a market, brings in hordes of...
The upscale gym chain Equinox announced Monday that it is partnering with lab-test startup Function Health to launch one of the most expensive gym...
Steward Health Care, the largest physician-led, for-profit hospital network in the United States, filed for bankruptcy Monday morning as it works to...
Amgen stock picked up 13% during Friday morning trading, a day after its CEO Robert Bradway teased encouraging trial results of its experimental...
Novo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and...
Sony Pictures and Apollo Global Management have made a $26 billion all-cash offer to buy Paramount Global, the parent company of CBS, MTV, and...
Novo Nordisk responded today to the U.S. Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and...
Novo Nordisk raised today both its full year sales and operational profit guidance for the year after reporting booming sales of its blockbuster...
The skyrocketing popularity of the diabetes drug Ozempic has put a heavy burden on public spending in Denmark, the home country of the drug’s...
Johnson & Johnson announced Wednesday that it plans to pay nearly $6.5 billion over 25 years to settle all pending and future U.S. lawsuits alleging...
Novo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on...
The U.S. Federal Trade Commission (FDA) announced on Tuesday that it is disputing over 300 patent listings across 20 different brand name drugs in an...
Eli Lilly stock jumped 5% during Tuesday morning trading to about $773 a share after the pharma giant reported better-than-expected sales of its...
Walmart announced today that it is closing all 51 of its health centers across five states and its virtual health care service due to a lack of...
Paramount Global, the parent company of CBS and MTV, announced late Monday that CEO Bob Bakish is stepping down from his role. Read more...
A dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food and Drug Administration (FDA) drug shortage...
Philips stock soared nearly 30% on Monday to over $27 after the the Dutch medical device maker announced it has agreed to pay $1.1 billion to resolve...
Paramount Global CEO Bob Bakish could be let go from the company as soon as today, according to various news outlets. Read more...
You may think that a class of drugs that has been shown to help users lose 15% to 20% of their body weight may put the fitness industry on edge. But...
The U.S. Food and Drug Administration (FDA) said on Thursday that genetic fragments of the H5N1 bird flu virus have been detected in one in five...
AbbVie raised its full year profit guidance today, even as sales of its flagship medication have continued to fall. Read more...
login
who are we?
contact us
qosheapp
